Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora

BACKGROUND: Severe liver diseases, such as liver fibrosis, cirrhosis, and liver cancer, are mainly caused by hepatitis B virus (HBV). This study investigated the differences between gut microbiota in HBeAg-positive and negative groups of patients with chronic hepatitis B (CHB) and investigated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Jianfei, Gong, Jingru, Zhu, Han, Liu, Xiaolin, Li, Ling, Chen, Bicui, Ren, Hongyan, Liu, Chao, Lu, Huiping, Zhang, Jiming, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548823/
https://www.ncbi.nlm.nih.gov/pubmed/37799607
http://dx.doi.org/10.3389/fmicb.2023.1232180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548823/
https://www.ncbi.nlm.nih.gov/pubmed/37799607
http://dx.doi.org/10.3389/fmicb.2023.1232180

Ejemplares similares